A Foray Into European Markets
Hyderabad's HRV Pharma is taking its business into Europe. The Times of India reports that the company will acquire Germany's Phatebo GmbH, marking its entry into finished formulations and European markets.
Introducing Phatebo GmbH
Phatebo is based in Hilzingen and has been in business since 2015. It specialises in clinical trial supply, sourcing comparator, investigational and ancillary medicines for pharmaceutical companies and clinical research organisations around the world. It reported revenue of about ₹350 crore in 2025.
Established Regulatory and Distribution Capabilities
What makes the deal valuable is what comes with it. Phatebo holds a German pharmaceutical wholesale authorisation, runs quality systems built for good distribution practice, and has long standing relationships with trial sponsors. Building all of that from scratch in Europe would take years.
Strengthening HRV's European Presence
For HRV, it means a licensed base on the continent, sitting right alongside an API business that already serves customers in 55 countries.
Featured in The Times of India
